Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joshua Ruch currently holds 14,019 shares of INOTEK PHARMACEUTICALS CORP (ITEK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua Ruch has been a net seller of ITEK stock. They have purchased $5.7M and sold $6.1M worth of shares.
Joshua Ruch's most recent insider trade was on Nov 24, 2025, when they sold 625 shares at $159.28 per share.
Joshua Ruch serves as Executive at INOTEK PHARMACEUTICALS CORP (ITEK). They have executed 41 insider transactions totaling $11.8M over their tenure at the company.
Joshua Ruch holds the position of Executive at INOTEK PHARMACEUTICALS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Joshua Ruch has shown a selling trading pattern, with $5.7M in total purchases and $6.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joshua Ruch was on Apr 29, 2022, when they purchased $6.5M worth of SMFR shares. This transaction involved 1,632,963 shares at $4.00 per share.
Joshua Ruch currently owns 14,019 shares of INOTEK PHARMACEUTICALS CORP (ITEK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joshua Ruch's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joshua Ruch has 41 Form 4 filings on record as an insider at INOTEK PHARMACEUTICALS CORP.
Set alerts for Joshua Ruch and 40,000+ other insiders.